Endovascular treatment of aortoiliac occlusive disease using kissing stents in high-risk patients: Procedural results and long-term follow-up  by Mouanoutoua, Mouatou et al.
76A ABSTRACTS - Angiography & Interventional Cardiology 
1199-177 Diabetes Mellitus and Long-Term Impact on Renal 
Function in Patients With Renal Artery Stenosis 
Receiving Percutaneous Transluminal Renal 
Angioplasty and Stent Placement 
David S. Bromet Roy P. Venzon, David W. Butzel, Kimberly Oswald, Clifford J. 
Kavinsky, Gary L. Schaer, Jeffrey Snell. Rush-Presbyterian-St. Luke’s Medical Center. 
Chicago. IL 
Background: Renal function has been shown to stabilize or improve after percutaneous 
transluminal renal artery angioplasty (PTRA) with stent placement in some patients with 
renal artery stenosis @AS). We undertake this study to see if diabetes mellitus (DM) 
influences this observed benefit. 
Methods: From 7/1997 to 712002, 98 PTRAs with stents were performed for atheroscle- 
rotic RAS in 80 patients. Charts of these patients were reviewed retrospectively. Clinical 
and angiographic follow up with a mean of 17.6 f 15.6 months was obtained. 
Results: At baseline, 27 of 80 patients (34%) presented with DM. Serum creatinine (0) 
prior to intervention for the entire cohort was 1.50 * 0.59 mgldl. Patients with DM had a 
higher mean Cr at baseline compared to patients with no DM (1.74 * 0.58 v 1.37 * 0.56, 
respectively (P = 0.009). During the follow-up period, diabetics had increasing Cr levels 
with values of 1.85 * 0.57, 1.99 * 0.99,2.05 + 1.06 and 2.03 * 0.71 mgldl at 1 month, 6 
months, 1 year and 2 years, respectively. In contrast, non-diabetics had a decreasing 
trend in Cr. with levels of 1.38 + 0.56, 1.33 + 0.60, 1.22 f 0.39 and 1.16 * 0.40 mg/dl. At 
2 years patients with diabetes had a higher Cr (P = 0.04) when compared to baseline. 
Conclusions: In patients who present with RAS and proceed to PTRA with stent place- 
ment, those without DM had a strong trend towards stabilization and improvement in 
serum Cr over time. In contrast, the patients with DM had worsening of renal function 
over time, a finding which becomes significant at two years. 
1199-197 Transluminal Endovascular Graft Placement With 
INOUE Stent Graft Is Effective for Many Types of 
Aneurysms and Dissections 
Keita Odashiro, Kenichi Abe, Takeshi Kimura, Hideyuki Nosaka, Masakiyo Nobuyoshi, 
Kanji Inoue. Kokura Memorial Hospital, Kitakyushu, Japan, Takeda Hospital, Kyoto. 
Japan 
Background: Althouh endoluminal stent graft placement has evolved as a potential alter- 
native to open surgical repair, current technologies have limitation in managing severe 
bend or side branches of the lesions. The feasibility and efficacy of Transluminal Endo- 
vascular Graft Placement (TEGP) with INOUE stent graft for treatment of many types of 
aneurysms and dissectlons was investigated. Methods: From Aug.1997 to August 2002, 
We performed TEGP with INOUE stent graft in 103 patients(pts.) and 107 case@0 men 
and 23 women. mean age 73 years). Forty seven pts. were very high risk for open repair 
or good candidates for TEGP. The cases consist of 1 ascending, 22 thoracic, 16 dissect- 
ing, 9 thoraco-abdominal. 58 infra-renal abdominal aortic aneurysms and 1 common iliac 
artery aneurysm. Twenty of the cases had straight, 20 had single branched, 5 had dual 
branched, 8 had triple branched and 58 had bifurcated graft. Result: In all cases but one, 
stent grafts were implanted successfully to the intended sites. There were five early 
deaths because of shower embolism ,cerebral infarction and MRSA pneumonia in throm- 
bus-rich aneurysm cases. The other major complications were stroke, supra-mesentric 
artery embolism and transient post-spinal artery syndrome. In dissecting cases, there 
were no embolic events. The mean follow-up was 27 months (range, l-60 months). Fol- 
low-up studies demonstrated 11 endoleaks. Six type III endoleaks were caused by prob- 
lem stent grafts. Conclusion: TEGP with lnoue stem graft is less invasive and especially 
useful for high risk pts. lnoue stent can be used I” many types of aneurysms and dissec- 
tions involving major branches of aortic arch or having sever bending. This advantage is 
due to its high flexibility and side branch availability. 
1199-198 Penetrating Aortic Ulcer Treatment by Endovascular 
Stent-Graft Placement 
Holaer Eaaebrecht, Dietrich Baumgart, Axel Schmermund, Ulf Herold, Joerg 
Barkhausen, Heinz Jakob, Raimund Erbel, University Hospital Essen, Essen. Germany 
Background : Penetrating atherosclerotic ulcer (PAU, class 4 aortic dissection) of the 
aorta is increasingly recognized in patients with acute aortic syndromes. Given the high 
morbidity and mortality, endovascular stent-graft repair may be an attractive treatment 
alternative in selected patients. 
Patients and Methods : We prospectively evaluated safety and efficacy of endovascular 
stent-graft placement in 9 patients with PAU of the aorta. Eight (85%) patients presented 
with acute aortlc syndrome. Two pabents had contained aortic rupture with left hemotho- 
rax. With the patients under general anesthesia, stent-graft placement was performed 
using a transfemoral approach. 
Results : Endovascular stent-graft placement was technically successful in all patients 
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(mean stent diameter 34*7 mm (24-46 mm), mean length 90*17 mm (60- 130 mm). In 
one patient with PAU in the aortic arch, occlusion of the left subclavian arterv was 
induced by the stew-graft, but remained asymptomatic. All patients developed transient 
elevation of C-reactive orotein levels (13.2+5 ma/d11 and mild leukocvtosis (11.3+3.6/nl\ _ 1  I  
after the intervention. There were no neurological complications or deaths during the in- 
hospital period. Within a follow-up period of 15.9-g months, there was one endoleak 
which was successfully treated by additional stent-graft implantation. In one patient with 
indication for surgical revascularization of preexisting bilateral renal artery stenosis the 
patent stent-graft was explanted and the diseased aortic segment replaced by surgical 
graft. 
Conclusion : PAU is a rare but serious acute disease of the aorta with a high late of 
bleeding complications. Our experience suggests that endovascular stem-graft place- 
ment is a safe and effective therapeutic option. 
1199-199 Percutaneous Transluminal Angioplasty of 
lnfrapopliteal Arteries in Patients With Intermittent 
Claudication: Acute and One-Year Results 
Hans Krankenberq, Thilo Tiibler, Michael Schliiter, Center for Cardiology and Vascular 
Intervention, Hamburg, Germany 
Background. In advanced stages of infrapopliteal peripheral arterial occlusive disease 
(PAOD) with critical ischemia of the lower limb, the efficacy of percutaneous transluminal 
angioplasty (PTA) is well established. In contrast, PTA is currently not the therapy of 
choice in intermittent claudication (IC). In this prospective study, patients with IC were 
treated percutaneously. Technical aspects and long-term results are presented. 
Methods. In 81 patients (61 males [75%], age 71 + 11 years) with IC (Rutherford grade 2 
or 3), 104 interventions (23 patients with bilateral PTA) were performed. At baseline the 
relative/absolute walking distance (RWD/AWD) was 49 * 34 / 102 f 57 m, the ankle-bra- 
chial index (ABI) was 0.61 * 0.2 before and 0.49 f 0.2 after exercise. In 19 interventions 
(l&3%), the excimer laser technique was used, in 26 cases (25%) a total of 39 stems 
were implanted and in 59 legs balloon angioplasty was done. 
Results. Prlmaly angiographic success rate (residual stenosis < 30%) was 89.4%. RWD 
and AWD improved to 107 * 67 m and 167 + 74 m (p < 0.05 vs. baseline each), respec- 
tively, and the ABI at rest and after exercise increased to 0.88 f 0.13 and 0.72 f 0.19 (p 
< 0.05 vs. baseline each). Complications: One major groin hematoma requiring surgical 
repair. One minor hematoma, 1 distal embolic occlusion, 1 arteriovenous fistula, 1 com- 
partment syndrome and one vessel perforation were treated consewatively. After 12 
months. the primary patency rate was 66.3%, cumulative primary assisted patency rate 
was 81.9% and secondary patency rate was 91.5%. 
Conclusion. Revascularization of infrapopliteal arteries in patients with IC is feasible and 
associated with good clinical results and an encouraging long-term patency rate. The 
complication rate is low. 
1199-200 Endovascular Treatment of Aortoiliac Occlusive 
Disease Using Kissing Stents in High-Risk Patients: 
Procedural Results and Long-Term Follow-Up 
Mouatou Mouanoutoua, Suhail Allaqaband, Rajesh Maddikunta, Anjan Gupta, Tanvw K. 
Bajwa. Aurora Sinai/St. Luke’s Medical Centers, UW Medical School-Milwaukee Clinical 
Campus, Milwaukee, WI 
Background: Aotioiliac occlusive disease (AOD) is a major cause of claudication and 
limb-threatening ischemia. Surgical revascularization is associated with high mortality (2. 
4%) and morbidity (E-13%). Endovascular intewention (El) using kissing stents (KS) has 
been used as an alternative to surgery. However, the long-term results are unknown. 
Method: We retrospectively analyzed data on 50 patients who underwent El using KS for 
AOD at our institution during the last 7 years. Results: Patient demographics are shown 
in Table 1. 30% of the patients had total occlusion of the distal aorta andfor the iliac arter- 
ies. 12% received thrombolytics prior to stenting. The procedure was successful in all 50 
patients. There were no periprocedure vascular complications, myocardial infarctions or 
deaths. The mean length of hospital stay was 1.5 * 0.8 days. Mean ankle brachial index 
improved to 0.8*0.3 post-procedure. Primary patency during follow-up of 20.5r 12.3 
months was 92% while secondary patency rate was 100%. Amputation-free survival was 
100%. 92% of patients remained free of life-style limiting claudication. Conclusions: 
Endovascular treatment of AOD using KS can be performed with excellent procedural 
and clinical success. Long-term patency rate is comparable to surgical revascularization. 
Even in patients with serious comorbidities, there were no procedure-related complica- 
tions 
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Demographics of the Study Patents 
Age 62 f 6.4 years 
Sex (M/F) 20122 
Coronary Artery Disease 67% 
Left Ventricular Systolic Dysfunction (EF ~40%) 23% 
Diabetes 14% 
Current Smokers 44% 
Prior Stroke 15% 
Chronic Renal Insufficiency (Serum creatinine > 1.5mgldl) 15% 
Fontaine Stage Ilb 70% 
Fontaine Stage Ill 18% 
Fontaine Stage IV 12% 
Mean Ankle Brachial Index 0.3 * 0.2 
1199-201 Common Femoral Artery Percutaneous Intervention: 
Feasibility, Safety, and Clinical Outcomes 
Viiay G. Kalaria. Riyaz Bashir, Glenn Wang, Robert Schainfeld, Jeffrey Isner, Kenneth 
Rosenfield. St. Elizabeth’s Medical Center, Tufts University, Boston, MA. Krannert 
Institute of Cardiology, Indiana University, Indianapolis, IN 
Background: Common femoral artery (CFA) atherosclerotic lesions are traditionally 
treated surgically. We report our inittal experience of percutaneous intervention (PTA) for 
CFA disease. 
Methods: From January 1998 to December 2001,47 patients (53 limbs) undewent PTA 
of CFA lesions. Angiographlc (final diameter stenosis < 30%) and clinical success, proce- 
dural and clinical complications were noted for all the patients. Primary and secondary 
patency was determined using Duplex ultrasound or ankle-brachial index (ABI) criteria 
and life table method at 6 months and one year. 
Results: Procedure indication was Rutherford category 2-3 moderate-to-severe claudica- 
tion (70.2%), category 4 rest pain (8.5%), category 5-6 tissue loss (19.3%) and salvage 
of iatrogenic artery dissection (2%), respectively. Majority of the patients had ipsilateral 
Iliac disease (70%) and 38% had prior peripheral surgical revascularization. Angio- 
graphic success was achieved in 100% of patients and pre-diameter stenosis 77.4 +I/- 
14.9% was reduced to 22.4+1- 16.1%. Procedural complications included distal emboliza- 
tion (1.9%), and major hematomas (3.8%. all managed conservatively). None of the 
patients underwent emergency surgery or had procedure-related limb-loss. Pre-proce- 
dure ABI (0.61+ 0.18) improved at 6 month (0.72+ 0.16, p = 0.02) and one year 
(0.73+0.27, p = 0.06). Clinical symptoms improvement was moderate-to-marked (+2 to 
+3 scale) in 64%, and minimal (+l scale) in 15% of the patients. Primary and secondary 
patency rates were 87%, 97% at six-month, and 51%, 63% at one year, respectively. 
Conclusion: Early experience shows that CFA disease treatment with PTA is feasible 
and safe, and may serve as an alternative to surgery in selected patients. Favorable 
patency rates were noted in this small series of patients treated by experienced opera- 
tors. 
1199-202 Percutaneous intervention of Common Femoral Artery 
for the Treatment of Limb lschemia 
Huao A. Quintana, Jose A. Silva, Stephen R. Ramee, Stephen J. Jenkins, Tyrone J. 
Collins, Christopher J. White, Ochsner Clinic Foundation, New Orleans, LA 
Background: Significant atherosclerotic disease of the common femoral artery (CFA) 
occurs infrequently. It often represents an extension of aorta-iliac atherosclerotic dis- 
ease. Repolts of percutaneous intewentlon of this vessel an? scarce in the literature. 
Methods: Percutaneous angioplasty (PTA) (n=ll; 52%) with provisional stenting (n=9; 
48%) was performed in the CFA of 19 patients (pts) (age: 64.9+9.6 years, 65% males) 
and 20 vessels. The indication for the procedure was Rutheford class V: one patient 
(5.2%), class IV: 7 pts (36.6%), class III: 9 pts (47.4%), class II: 2 pts (10.5%). Procedural 
success was defined as final minimum diameter of < 30% and an increase in ankle-bra- 
chial index (ABI) z 0.15; and clmical success as procedural success and freedom from 
in-hospital amputation and death. 
Results: Procedural success was obtained in 18 pts (94.7%) and clinical swcess was 
attamed in 17 pts (89.5%). ABI improved from 0.54+0.21 at baseline, to 0.63+0.16 after 
the procedure (p=O.O02). At a mean follow up of 11.4+6 (range, 2-24 months), Rutheford 
class improved at least by one functional class in 17 patients (89.5%) (p=O.O36). No 
patient required amputation or died at follow up. One patient (5.3%) required an addi- 
tional ipsilateral fern-pop bypass and one patient required ipsilateral iliac PTA and stent- 
,ng. 
Conclusions: PTA with provisional stenting of the CFA in pts with significant ischemia of 
the lower extremitws, IS associated with an excellent procedural and clinical success and 
a low complication rats. 
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867 Percutaneous Coronary Intervention and 
Optimal Pharmacology 
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867-l Correlation Between Statin Therapy Before 
Percutaneous Coronary Intervention, Periprocedural 
Creatine Kinase-MB Release, and Mortality at Follow-Up 
Annapoorna S. Kink Paul Lee, Cristina A. Mitre, Ajay Agarwal, Shazia Mukaddam, 
Michael C. Kim, Samin K. Sharma, The Mount Sinai Medical Center, New York, NY, The 
University of Toronto, Toronto, ON, Canada 
Background - Statin therapy has been shown to reduce mortality in patients with coro- 
nary ariery disease. However, the effect of statin therapy before percutaneous coronary 
intervention (PCI) on acute and long-term outcome after PCI has not been well e&b- 
lished. 
Methods - We analyzed 4660 PCI patients for in-hospital events and l-year moltality 
and compared the results between patients receiving statin therapy (PS. n=2970, 63.7%) 
and no-statin therapy (NS, n=1690, 36.3%) prior to PCI. All patients had CK-MB and Tnl 
measured at baseline and 12-24 hrs after PCI. All PS patients continued statins after 
PCI. 
Results -Any CK-MB elevation was 15.4% versus 14.4% (p=O.37) in NS versus PS 
group. Troponin-I release, procedural complications, and clinical success rate were simi- 
lar in the 2 groups. At follow-up, pre-statin therapy was an independent predictor 
(HR=0.65, 95% Cl 0.45-0.93; p-zO.0007) of survival (Figure). Other important baseline 
predictors of mortality were LVEF (HR=1.20), age (HR=1.03), peripheral vascular dis- 
ease (tfR=1.35), symptomatic hearl failure (H&1.42), and renal failure (HR=2.01). 
There was no difference in follow-up Ml or revascularization. 
Conclusions- Statins have a beneficial effect on survival even in PCI patients. This sur- 
vival benefit is mediated by other pleiotropic effects of statins and not by reduction of 
peri-procedural enzyme release or follow-up Ml or revascularization. 
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867-2 Abciximab Readministration: Final Results of the 
Reopro” Readministration Registry 
Jean-Pierre Dery, Gregory A. Braden, A. Michael Lincoff, Dean J. Kereiakes, Kevin F. 
Browne. Thomas Little, Barry S. George, Mark 8. Effron, Maly Ann Mascelli. Maly Ann 
Langrall, Lakshmi Damaraju, Elliot S. Barnathan, James E. Tcheng, Duke University 
Medical Center, Durham, NC 
??ackground:Clinical outcomes of patients undergomg percutaneous coronary interven- 
tion can be improved by blocking platelet glycoprotein Ilb/llla with abciximab (ReoPro). 
Interim results of the Reopro Readministration Registry documented both efficacy and 
safety of abciximab readministration. The final results of this registry are presented. 
Methods: A total of 1342 patients receiving abciximab for at least a second time were 
recruited from 24 centers in the United States. The safety endpoints assessed wars the 
risks of hypersensitivity, major bleeding, thrombocytopenia (TCP), and human antichi- 
merit antibody (HACA) response. Event-free clinical ?.~ccess of the procedure was used 
to determine efficacy. 
Results: Procedural success was 98% overall, and was not influenced by the number of 
readministrations or by the presence of positive HACA titers prior to readministration 
(which occurred in 5.6%). There were no cases of anaphylaxis, only 5 minor allergic 
reactions, none of which required termination of the infusion. Major bleeding occurred in 
2.2%, including 1 (0.07%) mtracranial hemorrhage. TCP (cl00 x lo9 A and 25% 
decrease from baseline) developed in 5.0%, whereas profound TCP (~20 x lo9 A) 
occurred in 2.0%. The incidence of TCP tended to fall as the time between administra- 
tions lengthened. Having a positive HACA titer prior to readministration did not correlate 
with adverse clinical outcomes or bleeding, but was associated with an increased inci- 
